Pain Medicine, Interventional Pain Medicine · Montgomery, AL
NPI
1205982998
Since 2007
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2065 E South Blvd, 401
Montgomery, AL, 36116
Phone (334) 288-7808
Groups this clinician bills Medicare through
Medicare paid, 2024
$677K
68,719 services
Medicare patients, 2024
834
Average age 72
Drug cost, 2024
$891K
24,833 prescriptions
Company payments, 2025
$1,236
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David P Herrick was code J1010 (injection, methylprednisolone acetate, 1 mg), 53,362 times for 390 patients. In total David P Herrick billed 68,719 services in 59 codes, and Medicare paid $677K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 53,362 | 390 | $0.10 | $5,332 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,543 | 191 | $0.09 | $394 |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 2,087 | 352 | $0.11 | $220 |
| 99214 Office E&M - Established | Office | 1,723 | 561 | $85.16 | $147K |
| 80307 Drug Tests | Office | 947 | 412 | $57.02 | $54K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 665 | 346 | $153.46 | $102K |
| 62323 Nerve Block Injection - Back | Office | 372 | 205 | $164.30 | $61K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 266 | 161 | $101.72 | $27K |
| 99442 Telephone Services | Office | 259 | 136 | $63.55 | $16K |
| 64483 Nerve Block Injection - Back | Office | 199 | 109 | $197.15 | $39K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 195 | 35 | $0.46 | $89.85 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 193 | 168 | $7.18 | $1,385 |
| 27096 Joint Injection | Office | 173 | 106 | $130.56 | $23K |
| 62321 Nerve Block Injection - Back | Office | 137 | 83 | $167.08 | $23K |
| 96127 Behavioral Health Services | Office | 109 | 101 | $3.08 | $336 |
By year: 2022 $635K for 25,332 services; 2023 $669K for 14,599 services; 2024 $677K for 68,719 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 947 | 412 | $57.02 | $54K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 665 | 346 | $153.46 | $102K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 266 | 161 | $101.72 | $27K |
Medicare prescription drug claims, 2024
In 2024, the drug David P Herrick prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 5,737 prescriptions and refills. In total David P Herrick wrote 24,833 Medicare prescriptions that cost $891K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 5,737 | 5,744 | 925 | $105K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,849 | 3,852 | 599 | $96K |
| Gabapentin Generic | 3,115 | 3,162 | 592 | $34K |
| Tizanidine Hcl Generic | 2,825 | 3,116 | 649 | $22K |
| Baclofen Generic | 1,088 | 1,182 | 205 | $10K |
| Tramadol Hcl Generic | 1,071 | 1,074 | 215 | $8,942 |
| Cyclobenzaprine Hcl Generic | 929 | 941 | 214 | $6,629 |
| Pregabalin Generic | 898 | 907 | 200 | $23K |
| Methocarbamol Generic | 713 | 720 | 192 | $7,725 |
| Morphine Sulfate Er Morphine Sulfate | 620 | 622 | 88 | $21K |
| Meloxicam Generic | 366 | 370 | 80 | $972 |
| Buprenorphine Generic | 353 | 353 | 71 | $103K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 324 | 324 | 92 | $4,615 |
| Duloxetine Hcl Generic | 298 | 314 | 57 | $3,791 |
| Amitriptyline Hcl Generic | 280 | 314 | 59 | $2,613 |
Brand drugs: 746 claims; generic drugs: 24,087 claims; opioid claims: 13,009.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David P Herrick $1,236 ($1,236 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbott Laboratories with $767.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.